Bora CDMO Bora CDMO

X

CAS 168828-82-8 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 168828-82-8
Also known as: 168828-82-8, (5r)-3-(3-fluoro-4-(4-morpholinyl)phenyl)-5-hydroxymethyl-2-oxazolidione, Pnu-100440, V7v7qjb5qj, ((r)-3-(3-fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl)methanol, (5r)-3-[3-fluoro-4-(morpholin-4-yl)phenyl]-5-(hydroxymethyl)-1,3-oxazolidin-2-one
Molecular Formula
C14H17FN2O4
Molecular Weight
296.29  g/mol
InChI Key
OLDRPBWULXUVTL-LLVKDONJSA-N
FDA UNII
V7V7QJB5QJ

1 2D Structure

CAS 168828-82-8

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(5R)-3-(3-fluoro-4-morpholin-4-ylphenyl)-5-(hydroxymethyl)-1,3-oxazolidin-2-one
2.1.2 InChI
InChI=1S/C14H17FN2O4/c15-12-7-10(17-8-11(9-18)21-14(17)19)1-2-13(12)16-3-5-20-6-4-16/h1-2,7,11,18H,3-6,8-9H2/t11-/m1/s1
2.1.3 InChI Key
OLDRPBWULXUVTL-LLVKDONJSA-N
2.1.4 Canonical SMILES
C1COCCN1C2=C(C=C(C=C2)N3CC(OC3=O)CO)F
2.1.5 Isomeric SMILES
C1COCCN1C2=C(C=C(C=C2)N3C[C@@H](OC3=O)CO)F
2.2 Other Identifiers
2.2.1 UNII
V7V7QJB5QJ
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 168828-82-8

2. (5r)-3-(3-fluoro-4-(4-morpholinyl)phenyl)-5-hydroxymethyl-2-oxazolidione

3. Pnu-100440

4. V7v7qjb5qj

5. ((r)-3-(3-fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl)methanol

6. (5r)-3-[3-fluoro-4-(morpholin-4-yl)phenyl]-5-(hydroxymethyl)-1,3-oxazolidin-2-one

7. (5r)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-5-(hydroxymethyl)-2-oxazolindinone

8. (r)-5-(hydroxymethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one

9. (5r)-3-(3-fluoro-4-morpholin-4-ylphenyl)-5-(hydroxymethyl)-1,3-oxazolidin-2-one

10. (5r)-3-(3-fluoro-4-morpholinophenyl)-5-(hydroxymethyl)oxazolidin-2-one

11. (r)-5-(hydroxymethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one, (-)-

12. 2-oxazolidinone, 3-(3-fluoro-4-(4-morpholinyl)phenyl)-5-(hydroxymethyl)-, (5r)-

13. Unii-v7v7qjb5qj

14. Mfcd06658241

15. (5r)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-5-hydroxymethyl-2-oxazolidione

16. (5r)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-5-(hydroxymethyl)-2-oxazolidinone

17. Chembl596913

18. Schembl2829206

19. Dtxsid90441549

20. Act01858

21. Zinc21298212

22. Akos005063828

23. Akos015919719

24. Ac-4277

25. Ds-1756

26. Cs-0030812

27. 828f828

28. Q-100203

29. Q27291642

30. 5(r)-hydroxymethyl-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one

31. (5r)-3-(3-fluoro-4-morpholinophenyl)-5-(hydroxymethyl)oxazolidine-2-one

32. 5(r)-hydroxymethyl-3-(4-morpholino-3-fluoro-phenyl)oxazolidin-2-one

33. (5r)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-5-(hydroxymethyl)-1,3-oxazolidin-2-one

34. (5r)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-5-(hydroxymethyl)-2oxazolidinone

35. (5r)-5-(hydroxymethyl)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxazolidinone

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 296.29 g/mol
Molecular Formula C14H17FN2O4
XLogP30.7
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count6
Rotatable Bond Count3
Exact Mass296.11723519 g/mol
Monoisotopic Mass296.11723519 g/mol
Topological Polar Surface Area62.2 Ų
Heavy Atom Count21
Formal Charge0
Complexity378
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag India
Digital Content Digital Content
168828-82-8
Sigmak Lifesciences is a leading contract manufacturer, merchant exporter, & distributor of pharmaceutica...
Sigmak Lifesciences is a leading contract manufacturer, merchant exporter, & distributor of pharmaceutical APIs & Fine Chemicals. We excel in Contract Manufacturing, covering a wide spectrum of intermediates, including advance intermediates, cGMP, & non-GMP intermediates. We represent GMP and WHO-certified manufacturers of APIs & advanced intermediates, offering Distribution & Agency services with rigorous selection processes & regular audits to guarantee top-quality products. Moreover, our global Strategic Sourcing capabilities provide high-quality ingredients & performance chemicals to the Pharmaceuticals & Specialty Chemical Industries.
Sigmak Lifesciences CB

EMWA 2024

Not Confirmed

envelop Contact Supplier
Flag China
Digital Content Digital Content
URL Supplier Web Content
168828-82-8
Beijing Zhongshuo Pharmaceutical Technology Development Co., Ltd. (BJ Zhongshuo) was established in 2001....
Beijing Zhongshuo Pharmaceutical Technology Development Co., Ltd. (BJ Zhongshuo) was established in 2001. It came from a subsidiary company of China National Pharmaceutical Industry Company affiliated to China National Pharmaceutical Group (CNPIC). BJ Zhongshuo runs a medicine R&D centre in Beijing Economic-Technological Development Area with over 20 experienced specialists and a batch of advanced equipment for experiment and detection. The centre deals with the R&D for innovated drugs and Generic drugs as well as the optimization and improvement on exiting products. The R&D centre is now able to deal with 10-15 new products per year.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY